News
The expectations that companies deal with sustainability risks are increasing. The pressure is also growing in the pharmaceutical industry. At first glance, the highly regulated industry does not need to worry too much in the so-called ESG area. However, controversies are looming, especially when it comes to social criteria.
By Eugenie Ankowitsch
With the planned amendment of the Ecodesign Directive and the right to repair, the EU Commission wants to come closer to the goal of a circular economy. For many companies, this would mean a deep intervention in their business model.
By Leonie Düngefeld
China plans to set up a trading scheme for green power. But a nationwide platform is still in its infancy. Meanwhile, ongoing reforms of the electricity market are contributing to making the trade of electricity from wind and sun more feasible in the future. Corporate demand for green power is high.
By Christiane Kuehl